Concord Medical Services Holdings Ltd
Close on Oct 19, 2026
About Concord Medical Services
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
Concord Medical Services Holdings Limited operates oncology healthcare facilities and provides medical equipment solutions in China. The company operates across two primary segments: hospital business and network business. Through its healthcare facilities, it delivers cancer care across the treatment continuum to patients, including screening, diagnosis, radiation therapy, and inpatient services. Through its network business, the company leases radiotherapy and diagnostic imaging equipment, sells medical devices, and offers technical support, management, teleconsultation, and medical software solutions to partner hospitals and other healthcare enterprises.
In China, the company operates four self-owned healthcare facilities, comprising one comprehensive cancer hospital, two cancer diagnosis and treatment clinics, and one imaging diagnosis center. Additionally, it supports eight cooperative centers established within six partner hospitals spanning six cities across five Chinese provinces and administrative regions. The company's principal executive offices are located in Beijing, China, and it maintains a registered office in the Cayman Islands.
Summary of the business section of Concord Medical Services's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Concord Medical Services Holdings Ltd
- Founded
- 2007
- Headquarters
- Chaoyang District, Beijing, China
- Address
- Room 26a1-26a5, East Tower, Hanwei, Building No. 7 Guanghua Road 100020
- Phone
- (86)10-5825-6867
- Website
- ccm.cn
- Employees
- 610, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Incorporated in
- E9
- Auditor
- Shandong Haoxin Certified Public Accountants Co., Ltd., Weifang, Peoples Republic of China
Stock & identifiers
- Ticker
- CCM
- Exchange
- NYSE
- IPO date
- Dec 11, 2009
- Shares outstanding
- 130M, Dec 31, 2025
- Filer category
- Non-accelerated filer
- Stock splits
- 1-for-10 reverse, Jul 30, 2024
- SEC CIK
- 1472072
- CUSIP
- 206277204
- ISIN
- US2062772049
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Jianyu Yang | Chief Executive Officer, Director | 466,097 |
| Botao Shi | Interim CFO | 477,000 |
| Wei (NMN) Jiang | Chief Financial Officer | – |
| Liping Zhang | Director | 135,000 |
| Zheng Cheng | Director | – |
| Wayne (NMN) Yu | Director | – |
| Hongzhong Liu | Director | – |
Employees
Headcount reported in annual reports
“We had 727,595 and 610 employees as of December 31, 2023, 2024 and 2025, respectively.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 30, 2021 | Late filing | Notification of late filing |
| Dec 11, 2009 | IPO | Initial public offering priced (424B4 prospectus) |
| Nov 27, 2009 | Listing | Registration of securities on an exchange (Form 8-A) |